BONNIE DAVIS: Open Payments
NPI 1598746190 · SAINT PETERSBURG, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$969 in 51 payments from 12 companies in 2025. Trend: 2023 $617 · 2024 $849 · 2025 $969
Food & beverage: $969
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $224 |
| ABBVIE INC. | 7 | $169 |
| Amgen Inc. | 11 | $152 |
| AstraZeneca Pharmaceuticals LP | 7 | $109 |
| GlaxoSmithKline, LLC. | 3 | $91 |
| Exact Sciences Corporation | 3 | $65 |
| Lilly USA, LLC | 2 | $37 |
| PFIZER INC. | 2 | $36 |
| Boston Scientific Corporation | 1 | $25 |
| Abbott Laboratories | 1 | $24 |
Products named: AIRSUPRA, OTEZLA, QULIPTA, TRELEGY ELLIPTA, Rybelsus, Cologuard Collection Kit, Ozempic, Wegovy.
Industry payments across FL — which companies pay providers there.
